NFKB1 and mantle cell lymphoma: Interestingly, ATG5 positively regulates TG2/NF-κB/IL6 signaling, suggesting a positive feedback loop, whose disruption may constitute a good therapeutic strategy to overcome drug resistance in MCL [179].